Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erman Cakal

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Journal of Diabetes|March 3, 2021
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)Alper Sonmez, Ibrahim Demirci, Cem Haymana, et al.
Internal Medicine Journal|December 23, 2021
No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort studyIbrahim Demirci, Tevfik Demir, Selcuk Dagdelen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 12, 2021
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)Ibrahim Sahin, Cem Haymana, Tevfik Demir, et al.
Endokrynologia Polska|February 4, 2022
Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide studyIbrahim Demirci, Cem Haymana, Ilker Tasci, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 16, 2021
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide StudyRifat Emral, Cem Haymana, Ibrahim Demirci, et al.
Diabetes Research and Clinical Practice|March 20, 2021
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in IstanbulIlhan Satman, Ibrahim Demirci, Cem Haymana, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Journal of Diabetes|March 3, 2021
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia)Alper Sonmez, Ibrahim Demirci, Cem Haymana, et al.
Internal Medicine Journal|December 23, 2021
No association of Gaucher disease with COVID-19-related outcomes: a nationwide cohort studyIbrahim Demirci, Tevfik Demir, Selcuk Dagdelen, et al.
Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [And] German Diabetes Association|August 12, 2021
Clinical Characteristics and Outcomes of COVID-19 Patients with Overweight and Obesity: Turkish Nationwide Cohort Study (TurCObesity)Ibrahim Sahin, Cem Haymana, Tevfik Demir, et al.
Endokrynologia Polska|February 4, 2022
Higher rate of COVID-19 mortality in patients with type 1 than type 2 diabetes: a nationwide studyIbrahim Demirci, Cem Haymana, Ilker Tasci, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 16, 2021
Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide StudyRifat Emral, Cem Haymana, Ibrahim Demirci, et al.
Diabetes Research and Clinical Practice|March 20, 2021
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in IstanbulIlhan Satman, Ibrahim Demirci, Cem Haymana, et al.
Pageof 12